IRIS Accounts Production v24.1.9.2 13810481 director 1.1.23 31.12.23 31.12.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh138104812022-12-31138104812023-12-31138104812023-01-012023-12-31138104812021-12-20138104812021-12-212022-12-31138104812022-12-3113810481ns15:EnglandWales2023-01-012023-12-3113810481ns14:PoundSterling2023-01-012023-12-3113810481ns10:Director12023-01-012023-12-3113810481ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3113810481ns10:SmallEntities2023-01-012023-12-3113810481ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3113810481ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3113810481ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3113810481ns10:FullAccounts2023-01-012023-12-3113810481ns10:OrdinaryShareClass12023-01-012023-12-3113810481ns10:RegisteredOffice2023-01-012023-12-3113810481ns5:CurrentFinancialInstruments2023-12-3113810481ns5:CurrentFinancialInstruments2022-12-3113810481ns5:ShareCapital2023-12-3113810481ns5:ShareCapital2022-12-3113810481ns5:RetainedEarningsAccumulatedLosses2023-12-3113810481ns5:RetainedEarningsAccumulatedLosses2022-12-3113810481ns5:PlantMachinery2023-01-012023-12-3113810481ns5:ComputerEquipment2023-01-012023-12-3113810481ns5:PlantMachinery2022-12-3113810481ns5:ComputerEquipment2022-12-3113810481ns5:PlantMachinery2023-12-3113810481ns5:ComputerEquipment2023-12-3113810481ns5:PlantMachinery2022-12-3113810481ns5:ComputerEquipment2022-12-3113810481ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3113810481ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3113810481ns10:OrdinaryShareClass12023-12-3113810481ns5:RetainedEarningsAccumulatedLosses2022-12-3113810481ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-31
REGISTERED NUMBER: 13810481 (England and Wales)














CU MEDICAL SERVICES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023






CU MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 13810481)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


CU MEDICAL SERVICES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTOR: J S Gilbrook





REGISTERED OFFICE: 12 Fratton Road
Portsmouth
Hampshire
PO1 5BX





REGISTERED NUMBER: 13810481 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

CU MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 13810481)

STATEMENT OF FINANCIAL POSITION
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 54,197 625

CURRENT ASSETS
Debtors 5 245,985 241,751
Cash at bank and in hand 52,205 64,698
298,190 306,449
CREDITORS
Amounts falling due within one year 6 455,717 375,530
NET CURRENT LIABILITIES (157,527 ) (69,081 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(103,330

)

(68,456

)

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 8 (103,430 ) (68,556 )
SHAREHOLDERS' FUNDS (103,330 ) (68,456 )

CU MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 13810481)

STATEMENT OF FINANCIAL POSITION - continued
31 DECEMBER 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12 July 2024 and were signed by:





J S Gilbrook - Director


CU MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 13810481)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1. STATUTORY INFORMATION

CU Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Computer equipment - 25% on reducing balance

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


CU MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 13810481)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 4 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 January 2023 - 833 833
Additions 83,869 - 83,869
At 31 December 2023 83,869 833 84,702
DEPRECIATION
At 1 January 2023 - 208 208
Charge for year 30,140 157 30,297
At 31 December 2023 30,140 365 30,505
NET BOOK VALUE
At 31 December 2023 53,729 468 54,197
At 31 December 2022 - 625 625

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 161,317 116,323
VAT 81,327 121,637
Prepayments and accrued income 3,341 3,791
245,985 241,751

CU MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 13810481)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 40,218 37,416
Amounts owed to associates 414,249 329,108
Social security and other taxes - 7,756
Accrued expenses 1,250 1,250
455,717 375,530

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100

8. RESERVES
Retained
earnings
£   

At 1 January 2023 (68,556 )
Deficit for the year (34,874 )
At 31 December 2023 (103,430 )